Schedule 13G ownership disclosure

Timber Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 887080109

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,047,364
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-000639
Form type
SC 13G/A
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jan 28, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub